Skip to content
Clinical Trials – home

Pulmonary congestion Diagnostics

1 / 1 trials open to patients1 country

In short

Pulmonary congestion, also known as pulmonary edema, is a serious condition that occurs when fluid builds up in the lungs, making it difficult to breathe. This medical emergency requires prompt attention and proper diagnosis to identify its underlying cause and begin appropriate treatment. Understanding when to seek diagnostic testing and what those tests involve can be crucial for protecting your health and potentially saving your life.

Key points

  • Pulmonary congestion is a medical emergency when symptoms appear suddenly—immediate diagnosis and treatment can save your life
  • Doctors can often diagnose pulmonary edema within minutes by listening to your lungs with a stethoscope and hearing distinctive crackling sounds
  • A simple, painless finger clip device can instantly measure your blood oxygen levels and reveal how severely the fluid is affecting your breathing
  • Chest X-rays are typically the first imaging test because they quickly confirm fluid in the lungs and help rule out other breathing problems
  • Blood tests measuring BNP levels can tell doctors whether your heart is under stress and causing fluid to back up into your lungs
  • People with heart failure have up to an 80 percent chance of experiencing pulmonary edema, making regular monitoring crucial
  • The diagnostic approach helps distinguish pulmonary congestion from similar conditions like pneumonia or pleural effusion, which require different treatments
  • Clinical trials use the same diagnostic tests as regular medical care but apply stricter criteria to ensure appropriate patient selection for research

Introduction: Who Should Undergo Diagnostics

If you experience sudden difficulty breathing, a feeling of suffocating or drowning, or a sensation of extreme shortness of breath that worsens when lying down, you need immediate medical attention. These could be signs of pulmonary edema, which is the medical term for fluid accumulation in the lungs. Anyone experiencing these symptoms should seek emergency care right away, as this condition can be life-threatening without prompt treatment.

Certain groups of people are at higher risk and should be particularly vigilant about respiratory symptoms. Older adults, especially those with existing heart problems, are more likely to develop pulmonary congestion. In fact, up to 80 percent of people with heart failure also experience pulmonary edema, and men are affected more often than women. If you have a history of heart disease, high blood pressure, kidney problems, or lung conditions, any new or worsening breathing difficulties warrant medical evaluation.

You should also seek diagnostics if you notice chronic symptoms that develop gradually over time. These may include waking up at night with sudden breathlessness, difficulty breathing during physical activity, swelling in your legs or feet, rapid weight gain, or persistent coughing that produces frothy sputum. Even if these symptoms seem mild at first, they can indicate an underlying problem that needs professional assessment.

People traveling to high altitudes should be aware of a special form of this condition called high-altitude pulmonary edema, or HAPE. This occurs when you rapidly ascend a mountain or travel to locations at high elevation where oxygen levels are lower. If you develop tiredness, weakness, shortness of breath, or chest tightness at high altitude, you need to descend immediately and receive medical evaluation.

Classic Diagnostic Methods

When you arrive at a hospital or emergency room with symptoms suggesting pulmonary congestion, healthcare providers will begin with a thorough physical examination. Your doctor will listen to your lungs and heart using a stethoscope. When fluid has accumulated in the lungs, doctors can often hear abnormal sounds called crackles or rales, which are distinctive crackling or bubbling noises that indicate fluid in the air sacs. They will also check for an increased heart rate, rapid breathing, and abnormal heart sounds that might point to underlying heart problems.

During the physical exam, your healthcare provider will look for other telltale signs. They may notice swelling in your legs or abdomen, which suggests fluid retention throughout the body. Your neck veins may appear distended or enlarged, which can indicate that too much fluid is present in your circulatory system. Your skin might appear pale or have a bluish tint, especially around the lips and fingertips, which signals that your body isn't getting enough oxygen.

A chest X-ray is typically the first imaging test performed when doctors suspect pulmonary edema. This simple and quick test can confirm the diagnosis by showing fluid accumulation in the lungs and can also help rule out other possible causes of your breathing difficulty, such as pneumonia or a collapsed lung. The X-ray provides a clear picture that allows doctors to see if your lungs appear congested with excess fluid.

Blood tests play an important role in diagnosing pulmonary congestion and understanding its cause. One particularly valuable test measures a substance called B-type natriuretic peptide, or BNP, which is a protein released by the heart when it's under stress. Elevated levels of BNP in the blood often signal a heart condition that could be causing fluid to back up into the lungs. Doctors also typically order a complete blood count to check for infection or anemia, metabolic panels to evaluate kidney function, and tests to assess thyroid function, as all of these conditions can contribute to or complicate pulmonary edema.

To measure how much oxygen is in your blood, healthcare providers use a test called pulse oximetry. A small sensor clips onto your finger or ear and uses light to determine your blood oxygen levels without needing to draw blood. This painless test provides immediate results and helps doctors understand how severely the fluid buildup is affecting your ability to get oxygen into your bloodstream. If more detailed information is needed, they may perform an arterial blood gas test, which involves drawing blood from an artery to measure precise levels of oxygen and carbon dioxide.

An electrocardiogram, or ECG (also called EKG), is another essential diagnostic tool. This test detects and records the electrical signals from your heart using small sensors attached to your chest, and sometimes your arms or legs. The ECG can reveal signs of thickening in the heart walls, previous heart attacks, or abnormal heart rhythms that might be causing or contributing to pulmonary congestion. The test is quick, painless, and provides valuable information about your heart's electrical activity and overall condition.

An echocardiogram uses sound waves to create moving images of your heart. This ultrasound examination allows doctors to see your heart's structure and watch how well it's pumping blood. The test can identify problems with the heart muscle, detect leaking or narrowed heart valves, and assess how effectively the heart's chambers are working. Because heart problems are the most common cause of pulmonary edema, the echocardiogram provides crucial information for diagnosis and treatment planning.

In some cases, doctors may need more detailed imaging. A chest CT scan, or computed tomography scan, provides more detailed pictures than a standard X-ray and can give additional information about the condition of the lungs and help identify or rule out pulmonary edema when the diagnosis is uncertain. This scan uses multiple X-ray images taken from different angles to create cross-sectional views of your chest.

Some patients may undergo additional specialized testing depending on their symptoms and suspected underlying causes. These tests help doctors distinguish pulmonary congestion from other conditions that can cause similar symptoms, such as pneumonia, which is an infection that fills air sacs with infected fluid, or pleural effusion, where fluid collects outside the lungs rather than inside them. Unlike pulmonary edema, pneumonia is caused by bacteria, viruses, or fungi, and the fluid is typically thicker and contains infection-fighting cells.

Diagnostics for Clinical Trial Qualification

When patients are being considered for enrollment in clinical trials studying treatments for pulmonary congestion or its underlying causes, they typically undergo a comprehensive set of diagnostic evaluations. These tests serve as standard criteria to ensure that participants truly have the condition being studied and that they can safely participate in the research.

Blood oxygen level measurements are fundamental screening tools for clinical trial participation. Both pulse oximetry and arterial blood gas testing help researchers establish baseline oxygen levels and assess the severity of impaired gas exchange in the lungs. These measurements help determine which stage or severity level of pulmonary edema a patient has, which is important because many trials focus on specific patient populations based on disease severity.

Imaging studies form another crucial component of trial qualification. Chest X-rays and sometimes CT scans are used not only to confirm the presence of pulmonary congestion but also to document its extent and characteristics. Researchers need this baseline imaging to later measure whether experimental treatments are helping reduce fluid accumulation in the lungs. These images also help exclude patients who have other lung conditions that might interfere with the trial or make it unsafe for them to participate.

Heart function testing through echocardiography is typically required for trials related to heart failure and cardiogenic pulmonary edema. The echocardiogram measures how well the heart is pumping, specifically looking at something called ejection fraction, which indicates what percentage of blood the heart pumps out with each beat. Many trials specifically seek patients with reduced ejection fraction or other defined heart problems to study targeted therapies.

Laboratory blood tests serve multiple purposes in trial screening. Beyond measuring BNP levels to assess heart stress, researchers check kidney function, electrolyte levels, blood cell counts, and liver function. These baseline values help ensure patient safety during the trial and provide comparison points to monitor for any side effects from experimental treatments. Patients with severe kidney or liver problems may be excluded from certain trials because these organs affect how the body processes medications.

Some research studies may use more specialized diagnostic procedures that aren't part of routine clinical care. For instance, trials studying new heart failure treatments might employ advanced imaging techniques or invasive monitoring with devices that measure pressures inside the heart and lungs. However, the core diagnostic approach relies on the same fundamental tests used in standard medical practice, simply applied more rigorously with strict inclusion and exclusion criteria to ensure appropriate patient selection for research participation.

Prognosis and Survival Rate

Prognosis

The outlook for people with pulmonary congestion depends heavily on its underlying cause and how quickly treatment begins. When pulmonary edema is caught and treated promptly, it is often a reversible condition, and faster treatment generally leads to better outcomes. The prognosis improves significantly when the underlying disease process causing the fluid buildup can be effectively managed.

Several factors influence how well a patient will do after experiencing pulmonary edema. Your overall health status, the strength of your immune system, whether you smoke, and whether you have other medical conditions all play important roles in recovery. The condition may improve quickly with appropriate treatment, or it may take longer depending on these individual circumstances. Some people may need to use breathing support machines for extended periods during their recovery.

For patients whose pulmonary congestion is caused by heart failure, the long-term outlook requires ongoing management of the heart condition. Most patients with chronic heart failure will experience at least one episode of acute pulmonary edema that requires hospital treatment. With proper medication, lifestyle changes, and regular medical care, many people can manage their condition and prevent future episodes.

If left untreated, pulmonary edema can be life-threatening. It can cause permanent organ damage and, when sudden and severe, may lead to respiratory failure or cardiac arrest due to lack of oxygen. This is why immediate medical attention is so critical when symptoms appear. The condition becomes more dangerous when treatment is delayed or when the underlying cause is severe or difficult to control.

Survival Rate

Pulmonary edema has a high mortality rate when not treated appropriately, making it a serious medical emergency that requires immediate care. For patients admitted to the hospital with acute pulmonary edema related to heart failure, the one-year mortality rate can be as high as 40 percent. This sobering statistic emphasizes the serious nature of the condition and the importance of both emergency treatment and long-term management of underlying causes.

More than one million patients are admitted to hospitals each year with a diagnosis of pulmonary edema secondary to cardiac causes, indicating how common and serious this condition is. The high admission numbers reflect both the prevalence of heart disease in the population and the emergency nature of acute pulmonary congestion.

Survival and recovery rates improve dramatically when patients receive prompt medical attention and appropriate treatment. Those who seek care immediately when symptoms begin, who receive proper emergency treatment including oxygen and medications, and who successfully treat the underlying condition have much better chances of survival and full recovery. Following up with regular medical care and adhering to prescribed treatments also significantly improves long-term survival for people who have experienced pulmonary edema.

Did you know?

  1. A simple finger clip device called a pulse oximeter can detect dangerously low oxygen levels in seconds without drawing any blood, helping doctors quickly assess how severely pulmonary congestion is affecting your breathing.
  2. The crackling sounds doctors hear through a stethoscope when listening to lungs with fluid buildup are sometimes described as sounding like crumpling cellophane or walking on fresh snow.
  3. Swimming and diving can cause a unique form of pulmonary edema when lung capillaries burst from pressure changes, even in competitive athletes who are otherwise perfectly healthy.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Pulmonary congestion

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Furosemide
  • Sponsor:Region Hovedstaden
See all 1 trials →filters applied: condition = Pulmonary congestion

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).